Physician profile
Don E Parish
NPI 1336672096
$1,020.87
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $104 · 2021: $482 · 2022: $434.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $301.52 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.53 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $117.40 | 2020-2022 | |
| Glaxosmithkline, LLC. | $116.25 | 2021-2022 | |
| Lilly USA, LLC | $108.50 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.86 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $43.53 | 2022 | |
| Merck Sharp & Dohme LLC | $41.39 | 2021 | |
| Amarin Pharma, INC. | $37.06 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $17.70 | 2021 | |
| Amgen INC. | $16.13 | 2022 | |
| Allergan, INC. | $14.60 | 2020 | |
| Abbott Laboratories | $12.40 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Don Parish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.